ArticleJugan geon-gang gwa jilbyeong2023
[Ophthalmologic Sentinel Surveillance Results, 2013-2022].
Article in Jugan geon-gang gwa jilbyeong, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Korea Disease Control and Prevention Agency has been operating an Ophthalmologic Sentinel Surveillance System since August 2003 to monitor the epidemic of epidemic keratoconjunctivitis (EKC) and acute hemorrhagic conjunctivitis (AHC), both of which are highly contagious eye diseases. From 36 weeks in 2013 to 53 weeks in 2022, the surveillance results showed a significant decrease in the average annual number of suspected cases of EKC, from 22.5 cases per 1,000 outpatients in 2018 to 4.0 in 2022. In particular, EKC showed a seasonal increase during the summer, peaking in August and September. Despite a significant decrease in suspected cases from 2020 to 2022, the seasonal epidemic pattern remained similar to previous years. Furthermore, the peak rate has decreased each year since 2016 (49.7 cases), but increased again in 2022 (9.0 cases). Contrastingly, suspected cases of AHC remained consistently low compared to EKC, without any seasonal epidemic pattern. Both diseases were most reported in the age group 0-6 years, with a significant decrease observed in all age groups after 2020, maintaining lower levels compared to pre-coronavirus disease 2019 (COVID-19) years. This decline is likely attributed to the implementation of COVID-19 control measures such as social distancing. However, as COVID-19-related measures have been gradually lifted, it is anticipated that the occurrence will gradually increase to pre-pandemic levels, emphasizing the importance of continuous monitoring.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.